De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation

Ji Wei Liu, Ping Sun, Qiu Yan, Amy S. Paller, Pedram Gerami, Nancy Ho, Neelam Vashi, I. Caroline Le Poole, Xiao Qi Wang*

*Corresponding author for this work

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

We have recently discovered that de-N-acetyl GM3 [NeuNH2-LacCer, d-GM3], a derivative of ganglioside GM3, is specifically expressed in metastatic tumor cells and that its expression correlates with an enhanced metastatic phenotype. Although the classic N-acetylated form of GM3 (NeuAcLacCer, c-GM3) is found in both normal and tumor cells, metastatic tumor cells (but not other cells) predominantly express d-GM3 (82-95% of total GM3). d-GM3 expression is mainly found in metastatic melanomas, but not in benign nevi or the majority of primary melanomas. Using metastatic (d-GM3-positive) and poorly invasive (d-GM3-negative) human melanoma cell lines, we found that d-GM3 stimulates cell migration and invasion by increasing the expression and activation of urokinase-like plasminogen activator (uPA). Further studies showed that d-GM3 activates matrix metalloproteinase-2 (MMP-2), but not MMP-9, when uPA receptor signaling is activated. These results implicate d-GM3 as a specific marker for metastatic melanoma and a novel therapeutic target for neoplastic diseases.

Original languageEnglish (US)
Pages (from-to)8662-8669
Number of pages8
JournalCancer Research
Volume69
Issue number22
DOIs
StatePublished - Nov 15 2009

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation'. Together they form a unique fingerprint.

Cite this